BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11944925)

  • 1. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6.
    Grieco P; Han G; Weinberg D; Van der Ploeg LH; Hruby VJ
    Biochem Biophys Res Commun; 2002 Apr; 292(4):1075-80. PubMed ID: 11944925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    J Med Chem; 2007 May; 50(10):2520-6. PubMed ID: 17455928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
    Grieco P; Cai M; Han G; Trivedi D; Campiglia P; Novellino E; Hruby VJ
    Peptides; 2007 Jun; 28(6):1191-6. PubMed ID: 17482720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and selective agonists of alpha-melanotropin (alphaMSH) action at human melanocortin receptor 5; linear analogs of alpha-melanotropin.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    Peptides; 2007 May; 28(5):1020-8. PubMed ID: 17376561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist.
    Han G; Quillan JM; Carlson K; Sadée W; Hruby VJ
    J Med Chem; 2003 Feb; 46(5):810-9. PubMed ID: 12593660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions.
    Haskell-Luevano C; Lim S; Yuan W; Cone RD; Hruby VJ
    Peptides; 2000 Jan; 21(1):49-57. PubMed ID: 10704719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
    Grieco P; Balse-Srinivasan P; Han G; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
    J Pept Res; 2003 Nov; 62(5):199-206. PubMed ID: 14531843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
    Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
    Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of novel melanotropin agonists and antagonists with high potency and selectivity for human melanocortin receptors.
    Cai M; Mayorov AV; Ying J; Stankova M; Trivedi D; Cabello C; Hruby VJ
    Peptides; 2005 Aug; 26(8):1481-5. PubMed ID: 15876475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119.
    Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE
    Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of the modified melanocortin peptides responsible for ligand selectivity at the human melanocortin receptors.
    Chen M; Georgeson KE; Harmon CM; Haskell-Luevano C; Yang Y
    Peptides; 2006 Nov; 27(11):2836-45. PubMed ID: 16730390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
    Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
    Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position.
    Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
    J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.